BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Damanakis AI, Ostertag L, Waldschmidt D, Kütting F, Quaas A, Plum P, Bruns CJ, Gebauer F, Popp F. Proposal for a definition of "Oligometastatic disease in pancreatic cancer". BMC Cancer 2019;19:1261. [PMID: 31888547 DOI: 10.1186/s12885-019-6448-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kubo H, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Yamazaki K, Todaka A, Sasaki K, Uesaka K. The Association Between Neoadjuvant Therapy and Pathological Outcomes in Pancreatic Cancer Patients After Resection: Prognostic Significance of Microscopic Venous Invasion. Ann Surg Oncol. [DOI: 10.1245/s10434-022-11628-8] [Reference Citation Analysis]
2 Szturz P, Vermorken JB. Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond. Cancers (Basel) 2021;13:2518. [PMID: 34063904 DOI: 10.3390/cancers13112518] [Reference Citation Analysis]
3 Kubo H, Ohgi K, Sugiura T, Ashida R, Yamada M, Otsuka S, Yamazaki K, Todaka A, Sasaki K, Uesaka K. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence. Ann Surg Oncol 2022. [PMID: 35381935 DOI: 10.1245/s10434-022-11662-6] [Reference Citation Analysis]
4 Gebauer F, Damanakis AI, Popp F, Quaas A, Kütting F, Lutz K, Held S, Deuß B, Göser T, Waldschmidt D, Bruns C. Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC). BMC Cancer 2021;21:1239. [PMID: 34794396 DOI: 10.1186/s12885-021-08966-3] [Reference Citation Analysis]
5 Macfie R, Berger Y, Sarpel U, Hiotis S, Golas B, Labow D, Cohen N. Surgical Management of Pancreatic Cancer Liver Oligometastases. Crit Rev Oncol Hematol 2022;:103654. [PMID: 35301097 DOI: 10.1016/j.critrevonc.2022.103654] [Reference Citation Analysis]
6 Schmidt T, Belyaev O, Uhl W, Bruns CJ. [Surgical treatment of pancreatic cancer-What is new?]. Chirurg 2022. [PMID: 35357553 DOI: 10.1007/s00104-022-01618-7] [Reference Citation Analysis]